Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 48 of 50:
38 39 40 41 42 43 44 45 46 47 48 49 50
Gene Compound Assay Inh Ic50 Ki View
5-hydroxytryptamine (serotonin) receptor 1A SULOCTIDIL Serotonin 5-HT1A 95% .5435uM .3106uM View
cholinergic receptor, muscarinic 5 PERHEXILINE Muscarinic M5 95% 1.0932uM .7854uM View
Cytochrom P450-2D6 monooxygenase THIORIDAZINE CYP450-2D6 Inhibition 95% 1.7726uM NoneNone View
Cytochrom P450-2D6 monooxygenase PERHEXILINE CYP450-2D6 Inhibition 95% .9408uM NoneNone View
adrenergic receptor, alpha 2a SULOCTIDIL Adrenergic alpha2A 95% 2.0232uM .7587uM View
5-hydroxytryptamine (serotonin) receptor 2C TERFENADINE Serotonin 5-HT2C 95% 1.231uM .645uM View
5-hydroxytryptamine (serotonin) receptor 2B PROPAFENONE Serotonin 5-HT2B 95% .092uM .058uM View
epidermal growth factor receptor IODOQUINOL Protein Tyrosine Kinase, EGF Receptor 95% 1.889uM NoneNone View
cholinergic receptor, muscarinic 3 DESLORATADINE Muscarinic M3 95% .446uM .095uM View
cholinergic receptor, muscarinic 2 DIMENHYDRINATE Muscarinic M2 95% .461uM .164uM View
cholinergic receptor, muscarinic 3 DIMENHYDRINATE Muscarinic M3 95% .447uM .095uM View
arachidonate 15-lipoxygenase, second type ISOPRENALINE Lipoxygenase 15-LO 95% 1.77uM NoneNone View
arachidonate 15-lipoxygenase ISOPRENALINE Lipoxygenase 15-LO 95% 1.77uM NoneNone View
arachidonate 15-lipoxygenase ISOPRENALINE Lipoxygenase 15-LO 95% 1.77uM NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, gamma subunit 7 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
adrenergic receptor, beta 3 ERGOCORNINE Adrenergic beta3 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
calcium channel, voltage-dependent, gamma subunit 6 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, gamma subunit 5 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
sodium channel, voltage-gated, type II, alpha 2 PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type I, beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
adrenergic receptor, alpha 2b TRAZODONE Adrenergic alpha2B 94% .389uM .178uM View
sodium channel, voltage-gated, type I, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 CLOPIDOGREL Serotonin Transporter 94% .562uM .299uM View
epidermal growth factor receptor CLOMIPHENE Protein Tyrosine Kinase, EGF Receptor 94% 1.05uM NoneNone View
cholinergic receptor, muscarinic 5 CLOMIPHENE Muscarinic M5 94% 1.771uM 1.272uM View
dopamine receptor D1A DROPERIDOL Dopamine D1 94% 1.092uM .546uM View
dopamine receptor D1A HALOPROGIN Dopamine D1 94% .563uM .282uM View
adrenergic receptor, beta 1 S-(-)-PROPRANOLOL Adrenergic beta1 94% .001908uM .001102uM View
adrenergic, beta-1-, receptor S-(-)-PROPRANOLOL Adrenergic beta1 94% .001908uM .001102uM View
adrenergic receptor, beta 3 S-(-)-PROPRANOLOL Adrenergic beta3 94% .165uM .124uM View
sodium channel associated protein 1 NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel associated protein 2 NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type III, beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type I, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type IX, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type VII, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
amiloride-sensitive cation channel 5, intestinal NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type III, beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type XI, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type I, beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type 10, alpha polypeptide NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type IV, alpha polypeptide NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type V, alpha polypeptide NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type II, beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, nonvoltage-gated 1 gamma NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, nonvoltage-gated 1 beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type XI, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, nonvoltage-gated 1, gamma NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, nonvoltage-gated 1, delta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
tachykinin receptor 2 SAQUINAVIR Tachykinin NK2 94% 6.214uM 2.071uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 RITONAVIR CYP450-3A4 Inhibition 94% .016uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B OXICONAZOLE Serotonin 5-HT2B 94% 4.6064uM 2.9314uM View
5-hydroxytryptamine (serotonin) receptor 2B OXYBUTYNIN Serotonin 5-HT2B 94% .792uM .504uM View
thromboxane A synthase 1 OXICONAZOLE Thromboxane Synthetase 94% .6174uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) OXICONAZOLE Thromboxane Synthetase 94% .6174uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C OXYMETAZOLINE Serotonin 5-HT2C 94% .578uM .303uM View
5-hydroxytryptamine (serotonin) receptor 2C ORPHENADRINE Serotonin 5-HT2C 94% .534uM .28uM View
adrenergic receptor, beta 1 ACEBUTOLOL Adrenergic beta1 94% .731uM .422uM View
adrenergic, beta-1-, receptor ACEBUTOLOL Adrenergic beta1 94% .731uM .422uM View
adrenergic receptor, beta 3 EBASTINE Adrenergic beta3 94% 2.5455uM 1.9091uM View
dopamine receptor 2 LEVOSULPIRIDE Dopamine D2L 94% .128uM .043uM View
cholinergic receptor, muscarinic 2 EBASTINE Muscarinic M2 94% .786uM .2795uM View
adrenergic receptor, alpha 2a PROMETHAZINE Adrenergic alpha2A 94% .681uM .256uM View
dopamine receptor D3 RALOXIFENE Dopamine D3 94% 1.565uM .531uM View
sodium channel, voltage-gated, type IV, beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel associated protein 1 PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel associated protein 2 PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type III, beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type I, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type IX, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type VII, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
amiloride-sensitive cation channel 5, intestinal PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type III, beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type XI, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type I, beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type 10, alpha polypeptide PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type IV, alpha polypeptide PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type V, alpha polypeptide PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type II, beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, nonvoltage-gated 1 alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, nonvoltage-gated 1 gamma PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, nonvoltage-gated 1 beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type XI, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, nonvoltage-gated 1, gamma PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, nonvoltage-gated 1, delta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, nonvoltage-gated 1 alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type X, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
gamma-aminobutyric acid A receptor, gamma 1 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid A receptor, pi ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
AT hook, DNA binding motif, containing 1 (DBSS) ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid A receptor, theta ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid A receptor, gamma 2 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid A receptor, alpha 2 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid A receptor, alpha 1 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid A receptor, delta ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 ZALEPLON GABAA, Benzodiazepine, Central 94% .412uM .336uM View
cholinergic receptor, muscarinic 2 GENTIAN VIOLET Muscarinic M2 94% 1.43uM .508uM View
adrenergic receptor, alpha 2b GENTIAN VIOLET Adrenergic alpha2B 94% 1.258uM .574uM View
adrenergic receptor, alpha 1d (Non-specific probe) BROMOCRIPTINE Adrenergic alpha1D 94% .03uM .015uM View
adrenergic receptor, alpha 2b BROMOCRIPTINE Adrenergic alpha2C 94% .52uM .076uM View
adrenergic receptor, alpha 2c (Non-specific probe) BROMOCRIPTINE Adrenergic alpha2C 94% .52uM .076uM View
5-hydroxytryptamine (serotonin) receptor 2C VERAPAMIL Serotonin 5-HT2C 94% .297uM .155uM View
5-hydroxytryptamine (serotonin) receptor 2C CITALOPRAM Serotonin 5-HT2C 94% .297uM .156uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 INDINAVIR CYP450-3A4 Inhibition 94% .4uM NoneNone View
calcium channel, voltage-dependent, beta 4 subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, beta 3 subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, beta 2 subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, alpha 1F subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, beta 1 subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 4 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, gamma subunit 3 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, gamma subunit 2 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, gamma subunit 1 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
5-hydroxytryptamine (serotonin) receptor 2C DIHYDROERGOCRISTINE MESYLATE Serotonin 5-HT2C 95% .239uM .125uM View
calcium channel, voltage-dependent, beta 4 subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, beta 3 subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, beta 2 subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, alpha 1F subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, beta 1 subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 FLUNARIZINE Calcium Channel Type L, Phenylalkylamine 95% .177uM .172uM View
Cytochrom P450-2C19 monooxygenase NOVARTIS P-38 INHIBITOR CYP450-2C19 Inhibition 95% .3uM NoneNone View
acetylcholinesterase (YT blood group) BERBERINE CHLORIDE Acetylcholinesterase 95% .774uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase BERBERINE CHLORIDE Acetylcholinesterase 95% .774uM NoneNone View
acetylcholinesterase BERBERINE CHLORIDE Acetylcholinesterase 95% .774uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 DOBUTAMINE Adrenergic, Norepinephrine Transporter 95% .383uM .38uM View
adrenergic receptor, alpha 1d (Non-specific probe) MAPROTILINE Adrenergic alpha1D 95% .397uM .195uM View
5-hydroxytryptamine (serotonin) receptor 2C BENZTROPINE Serotonin 5-HT2C 95% .061uM .032uM View
dopamine receptor D1A MAPROTILINE Dopamine D1 95% .373uM .187uM View
adrenergic receptor, beta 2 LISURIDE Adrenergic beta2 95% .041uM .029uM View
mu-opioid receptor MOR SPIRADOLINE Opiate mu 95% .234uM .095uM View
adrenergic receptor, alpha 2a CLONIDINE Imidazoline I2, Central 95% .064uM .043uM View
adrenergic receptor, alpha 2c (Non-specific probe) CLONIDINE Imidazoline I2, Central 95% .064uM .043uM View
dopamine receptor 2 LISURIDE Dopamine D2L 95% .00286uM .000953uM View
dopamine receptor 2 DIHYDROERGOCRISTINE MESYLATE Dopamine D2L 95% .001474uM .000491uM View
cholinergic receptor, muscarinic 3 PROMAZINE Muscarinic M3 95% .416uM .088uM View
sodium channel, nonvoltage-gated 1 beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
cholinergic receptor, muscarinic 1 TRIHEXYPHENIDYL Muscarinic M1 95% .005608uM .001351uM View
sodium channel, voltage-gated, type XI, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, nonvoltage-gated 1, gamma TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, nonvoltage-gated 1, delta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, nonvoltage-gated 1 alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type X, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type IX, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage gated, type VIII, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type VII, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type IX, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage gated, type VIII, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type VII, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type IV, beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type IV, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type III, alpha PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
sodium channel, voltage-gated, type II, beta PROPARACAINE Sodium Channel, Site 2 94% 1.407uM 1.283uM View
calcium channel, voltage-dependent, beta 1 subunit CARVEDILOL Calcium Channel Type L, Phenylalkylamine 95% .389uM .378uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CARVEDILOL Calcium Channel Type L, Phenylalkylamine 95% .389uM .378uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CARVEDILOL Calcium Channel Type L, Phenylalkylamine 95% .389uM .378uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CARVEDILOL Calcium Channel Type L, Phenylalkylamine 95% .389uM .378uM View
calcium channel, voltage-dependent, gamma subunit 8 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 7 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 6 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 5 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
sodium channel, voltage-gated, type I, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
calcium channel, voltage-dependent, gamma subunit 4 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 3 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 2 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, gamma subunit 1 CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, beta 4 subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, beta 3 subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, beta 2 subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, alpha 1F subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CARVEDILOL Calcium Channel Type L, Benzothiazepine 95% .621uM .552uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type IV, beta TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View
sodium channel, voltage-gated, type IV, alpha TERBINAFINE Sodium Channel, Site 2 95% 1.4026uM 1.2795uM View